Filter – News
- Announcement: Summary of professional services in 6CPAThe Pharmaceutical Society of Australia welcomes the signing of the Sixth Community Pharmacy Agreement. It brings surety to the community pharmacy sector after a period of uncertainty for the whole profession.
- Immunisation win for Tasmania as vaccination training soars
5 February 2016 A decision to allow trained pharmacists in Tasmania to administer influenza vaccines to adults has been welcomed by the Pharmaceutical Society of Australia (PSA), Australia’s peak body for pharmacists.
- Updating medicine ingredient names (member only content)
The Therapeutic Good Administration (TGA) has advised that from April 2016 it will be updating some medicine ingredient names used in Australia to align with names used internationally. The list below shows the medicine ingredient names that will be changing. To find the new name where there is to be a change, simply begin typing the name of the ingredient into the search box.
To see this content you need to log in.
- Cautionary advisory label update: Vinorelbine – posted 9 October 2015
Vinorelbine products available in Australia should be stored at 2 to 8°C. The recommended cautionary advisory labels for vinorelbine are: 6, 18, 21, A*, B*
- Cautionary advisory label update: Dabigatran – posted 9 October 2015
Table A1 of APF23 (page 18 of hard-copy book) contains the following cautionary advisory label (CAL) recommendations for dabigatran: 7b (30 days), 10b, 13, A The storage recommendation to discard the contents 30 days after opening refers to dabigatran when it is packaged in a bottle.
- Pharmacists in General Practices
PSA is seeking expressions of interest from pharmacies, GP surgeries and primary healthcare network for its GP-Pharmacist Connect service.
- Medicines labels help to minimise risk
May 8, 2015 A significant number of medicines have the potential to pose a health and safety risk as a result of unintended exposure when people other than the patient – such as carers, family members or healthcare professionals – handle the medicine.To help protect people from such exposure, the latest edition of the Australian Pharmaceutical Formulary and Handbook (APF23) contains a list of hazardous medicines that are:
- designated as pregnancy category X or D
- reported to pose a risk to patients or carers through inappropriate handling.
- Cautionary Advisory Labels in practice (posted 3 May 2015)
Cautionary Advisory Labels (CALs) produced by PSA are essential consumer resources that promote quality use of medicines. This article, from Australian Pharmacist March 2015, provides an update on the optimal use of CALs.
- APF23 tables
Table A3. Hard capsule sizes and filling weights
Table A6. Milligrams per millimole for ions and salts
Table A7. Isosmotic concentration, freezing point depression and sodium chloride equivalence for a range of substances
- Chapter: Biosimilar medicines (posted 18 February 2015, updated 9 December 2015)
The Biosimilar medicines chapter of APF23 (pages 94–96) contains details about the naming convention and interchangeability of biosimilars. Please note that information about biosimilar medicines is rapidly evolving and current guidance about biosimilar medicines is available on the TGA website https://www.tga.gov.au/publication/evaluation-biosimilars and the PBS website http://www.pbs.gov.au/info/publication/factsheets/biosimilars/biosimilar-medicines-factsheet-for-healthcare-professional